Can Iron Chelators Influence the Progression of Atherosclerosis?
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Epidemiological studies and experimental data suggest iron involvement in atherosclerosis. The relation between iron and atherosclerosis is complex and remains contradictory. In thalassemia patients, non transferrin bound iron (NTBI) and free hemoglobin (Hb) are present in plasma and may accelerate atherogenesis, but its progression may be inhibited by iron chelators. The mechanism whereby iron may stimulate atherogenesis has been intensively investigated. Non transferrin bound iron and sera from subjects with hemochromatosis induced endothelial activation with expression of vascular adhesion molecules and endothelial inflammatory chemokines. Such events could be inhibited by iron chelators and oxygen radical scavengers with intracellular activity. Iron chelators may be effective in preventing vascular damage in patients with high concentrations of NTBI as found in thalassemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Salonen, J. T., Nyyssönen, K., Korpela, H., Tuomilehto, J., Seppänen, R., & Salonen, R. (1992) · Circulation · doi:10.1161/01.cir.86.3.803 · Cited by 1,284
Sazawal, S., Black, R. E., Ramsan, M., Chwaya, H. M., Stoltzfus, R. J., Dutta, A., Dhingra, U., Kabole, I., Deb, S., Othman, M. K., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67962-2 · Cited by 981 · cited 1×
“In most studies, iron supplements that may increase NTBI, cause a higher risk of malaria mortality in children (59), probably by promoting cerebral vascular occlusion.”
BackgroundIRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK
Sullivan, J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92463-6 · Cited by 969 · cited 2×
“In 1981, Sullivan (13) postulated that iron depletion can protect against ischemic heart disease.”
BackgroundSmith, C., Mitchinson, M. J., Aruoma, O. I., & Halliwell, B. (1992) · Biochemical Journal · doi:10.1042/bj2860901 · Cited by 455 · cited 1×
“Moreover, the interior of advanced human atherosclerotic lesions is a highly prooxidant environment containing reduction-oxidation active iron and copper ions that induce lipid peroxidation (29).”
BackgroundDietary iron intake and risk of coronary disease among men.
Ascherio, A., Willett, W. C., Rimm, E. B., Giovannucci, E. L., & Stampfer, M. J. (1994) · Circulation · doi:10.1161/01.cir.89.3.969 · Cited by 286
Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease
Duffy, S. J., Biegelsen, E. S., Holbrook, M., Russell, J. D., Gokce, N., Keaney, J. F., & Vita, J. A. (2001) · Circulation · doi:10.1161/01.cir.103.23.2799 · Cited by 271 · cited 1×
“The vascular condition could be improved after administration of an iron chelator (42), or by iron depletion (43).”
BackgroundIron, Atherosclerosis, and Ischemic Heart Disease
de Valk, B., & Marx, J. J. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.14.1542 · Cited by 250
Self-citationEffect of Iron Chelation Therapy on Recovery from Deep Coma in Children with Cerebral Malaria
Gordeuk, V., Thuma, P., Brittenham, G., McLaren, C., Parry, D., Backenstose, A., Biemba, G., Msiska, R., Holmes, L., McKinley, E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272101 · Cited by 210 · cited 1×
“In such situations iron chelators may be beneficial (60,61).”
BackgroundIron-Deficient Diet Reduces Atherosclerotic Lesions in ApoE-Deficient Mice
Lee, T.-S., Shiao, M.-S., Pan, C.-C., & Chau, L.-Y. (1999) · Circulation · doi:10.1161/01.cir.99.9.1222 · Cited by 179 · cited 1×
“Dietary iron restriction also protected apoE-deficient mice from developing such lesions (33).”
BackgroundFerric saccharate induces oxygen radical stress and endothelial dysfunction in vivo
Rooyakkers, T. M., Stroes, E. S. G., Kooistra, M. P., Van Faassen, E. E., Hider, R. C., Rabelink, T. J., & Marx, J. J. M. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1009.x · Cited by 157 · cited 1×
“Several studies have shown the importance of iron to induce early functional and structural vascular abnormalities due to endothelial dysfunction(35) that is associated with induction of oxidative stress.”
BackgroundSelf-citation
Cited by
Kell, D. B., & Pretorius, E. (2014) · Metallomics · doi:10.1039/c3mt00347g · Cited by 667
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
Altamura, S., & Muckenthaler, M. U. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1010 · Cited by 369
“Furthermore, iron was suggested to modify the expression of transcription factors, cytokines, or growth factors that are involved in the formation of atherosclerotic lesions [154].”
BackgroundKell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…DePalma et al. 2010; Gozzelino et al. 2010; Howes et al. 2000; Kallianpur 2005; Kartikasari et al. 2009; Kiechl et al. 1997; Lapenna et al. 2007; Marx et al. 2008; McRae et al. 2009; Minqin et al. 2003; Ramakrishna et al. 2003; Ren et al. 2003; Salonen et al. 1992; Shah and Alam 2003; Sullivan…”
BackgroundIron in arterial plaque: A modifiable risk factor for atherosclerosis
Sullivan, J. L. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.06.005 · Cited by 176
Metadata
- Authors
- Marx, J. J. M., Kartikasari, A. E. R., & Georgiou, N. A.
- Venue
- Hemoglobin
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 32
- Issue
- 1-2
- Pages
- 123-134
- ISSN
- 0363-0269 (ISSN-L)
- 1532-432X
- OpenAlex
- W2139108355
- Cited by
- 18
- References
- 15
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Can Iron Chelators Influence the Progression of Atherosclerosis? https://app.cochat.ai/papers/10.1080/03630260701726871
- The paper
- Marx, J. J. M., Kartikasari, A. E. R., & Georgiou, N. A. (2008). Can Iron Chelators Influence the Progression of Atherosclerosis? Hemoglobin. https://doi.org/10.1080/03630260701726871
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.